Clinical trial

Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)

NCT00842712

Drugs and interventions used in this trial

11 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Cilengitide Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Cetuximab Normalized identity: cetuximabView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Cisplatin Normalized identity: cisplatinView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Gemcitabine Normalized identity: gemcitabineView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Vinorelbine Normalized identity: vinorelbineView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Cilengitide Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Cetuximab Normalized identity: cetuximabView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Chemotherapy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-02-01

PhasePHASE2

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Interventions

CilengitideDRUG

CetuximabDRUG · verified · RxNorm: cetuximab

CisplatinDRUG · verified · RxNorm: cisplatin

GemcitabineDRUG · verified · RxNorm: gemcitabine

VinorelbineDRUG · verified · RxNorm: vinorelbine

CilengitideDRUG

CetuximabDRUG · verified · RxNorm: cetuximab

ChemotherapyDRUG

Sponsors & collaborators

Merck KGaA, Darmstadt, Germanylead sponsor

Mapped research locations

BarcelonaSpain1 ParisFrance1 BerlinGermany1 WarsawPoland1 HamburgGermany1 MarseilleFrance1 BrusselsBelgium1 LyonFrance1 StrasbourgFrance1 LilleFrance1 BordeauxFrance1 LeuvenBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00842712 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.